Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Wald ratio,1,1.38 [1.28-1.49],5.39959137267394e-17,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,3,0.94 [0.9-0.97],0.000786827548271807,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,Wald ratio,1,0.93 [0.88-0.98],0.00806904847649597,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Wald ratio,1,0.93 [0.88-0.98],0.00933780146903435,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,4,1.09 [1.02-1.18],0.0181364939409878,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Wald ratio,1,1.2 [1.03-1.4],0.0209713735276091,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Wald ratio,1,1.13 [1.02-1.26],0.0209713735276091,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,21,0.95 [0.92-0.99],0.0239395458315558,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,2,0.8 [0.66-0.97],0.0254487998722177,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,5,0.96 [0.92-1],0.029521241651206,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_AVBLOCK,Inverse variance weighted,5,1.06 [1-1.12],0.0385211260321621,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Wald ratio,1,0.79 [0.63-0.99],0.0396962232410248,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,2,1.03 [1-1.06],0.0403885529781954,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,3,1.06 [1-1.11],0.0439483263919774,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,5,0.95 [0.9-1],0.0441444579013324,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_HYPTENSPOR,Wald ratio,1,1.03 [1-1.07],0.0519608600760987,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,2,1.04 [1-1.07],0.0552294431375498,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,5,1.2 [0.99-1.45],0.0694915621110746,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Wald ratio,1,0.93 [0.85-1.01],0.0767030542284494,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Wald ratio,1,1.45 [0.95-2.21],0.0821548973127595,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_ABAORTANEUR,Inverse variance weighted,5,0.94 [0.88-1.01],0.0881014991095852,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,122,0.98 [0.96-1],0.0905542849165091,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_AORTANEUR,Inverse variance weighted,18,0.97 [0.93-1.01],0.0944499618817726,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,J10_INTERSTITIUM,Inverse variance weighted,4,0.98 [0.96-1],0.106322145862409,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,10,0.96 [0.91-1.01],0.119301082466003,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Wald ratio,1,0.91 [0.81-1.03],0.124818805549217,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_INCLAVO,Inverse variance weighted,50,1.05 [0.98-1.13],0.142105223131169,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,25,1.1 [0.96-1.25],0.162366043384188,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,24,0.98 [0.96-1.01],0.167954308496847,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,0.98 [0.94-1.01],0.176296585058999,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,COLITNONINFNAS,Wald ratio,1,1.16 [0.94-1.43],0.178124800879903,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Wald ratio,1,0.81 [0.6-1.1],0.179065762087871,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,K11_PANCOTH,Wald ratio,1,0.93 [0.84-1.03],0.183514436830026,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,24,1.05 [0.98-1.14],0.184794882296284,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,1.09 [0.96-1.24],0.199361592820195,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,AB1_MYCOSES,Wald ratio,1,1.12 [0.94-1.34],0.199614281770074,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_PAD,Inverse variance weighted,2,1.04 [0.98-1.11],0.203850549952399,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,K11_DIVERTIC,Inverse variance weighted,50,1.02 [0.99-1.06],0.212335902016671,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,10,0.97 [0.91-1.02],0.226866163293402,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Wald ratio,1,1.05 [0.97-1.15],0.233789735084941,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,13,1.04 [0.98-1.1],0.234358884183782,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter V Mental and behavioural disorders,F5_DELIRIUM,Wald ratio,1,0.93 [0.82-1.05],0.240530683310298,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERBLOOD,Wald ratio,1,0.96 [0.9-1.03],0.263536403328706,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_UAP,Inverse variance weighted,24,0.98 [0.94-1.02],0.270740171105989,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Wald ratio,1,0.96 [0.9-1.03],0.290241232696509,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,2,1.07 [0.94-1.22],0.300636248516876,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,K11_OTHFUNC,Wald ratio,1,0.89 [0.71-1.12],0.312955575566653,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,2,1.06 [0.95-1.19],0.322435989287374,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,4,1.06 [0.95-1.18],0.335526494574695,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_LBBB,Inverse variance weighted,2,1.03 [0.97-1.08],0.352088167499401,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Wald ratio,1,0.9 [0.73-1.12],0.352469425797299,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,2,1.02 [0.97-1.08],0.354663359516652,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,COPD_HOSPITAL_MAIN,Inverse variance weighted,7,1.05 [0.94-1.17],0.356316453731644,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,14,0.99 [0.95-1.02],0.357714936918756,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,J10_LOWERINF,Wald ratio,1,0.89 [0.7-1.14],0.362535892724296,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSALGIANAS,Inverse variance weighted,2,1.06 [0.93-1.22],0.370319736922026,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS,Inverse variance weighted,51,1.03 [0.97-1.1],0.371990022427237,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Wald ratio,1,0.9 [0.71-1.14],0.374301259463858,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,4,1.03 [0.97-1.09],0.375652772209293,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,3,1.1 [0.89-1.35],0.388235127656699,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,20,1.01 [0.99-1.02],0.394008616521002,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_PHLETHROM,Inverse variance weighted,14,1.01 [0.98-1.04],0.414477098087426,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_NSTEMI,Inverse variance weighted,4,1.02 [0.98-1.06],0.438850756414029,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,5,1.04 [0.94-1.14],0.439692180007401,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_OTHARR,Inverse variance weighted,12,1.02 [0.97-1.08],0.442594063155291,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,16,0.97 [0.89-1.05],0.448442151430122,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_LOWBACKPAIN,Inverse variance weighted,10,1.04 [0.93-1.16],0.493140062226754,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,AB1_BACTINF_NOS,Inverse variance weighted,2,1.04 [0.92-1.18],0.49671100000141,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,11,1.03 [0.95-1.11],0.501624619070414,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,12,1.02 [0.96-1.09],0.526477589966811,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,6,0.98 [0.92-1.05],0.559812490376431,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OTHERJOINT,Inverse variance weighted,16,1.04 [0.9-1.21],0.567134322257448,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,21,1.01 [0.99-1.03],0.568980532115372,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,3,1.02 [0.95-1.1],0.586309624739668,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_PHLETHROMBDVTLOW,Inverse variance weighted,30,1.01 [0.98-1.03],0.606906999640342,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_PAROXTAC,Inverse variance weighted,7,1.01 [0.96-1.06],0.610172224787392,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,8,1.02 [0.95-1.08],0.625333822633616,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_CARDMYOOTH,Inverse variance weighted,2,1.02 [0.95-1.08],0.636468600414224,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Wald ratio,1,1.04 [0.87-1.25],0.643362587987005,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,35,1.01 [0.97-1.05],0.654549524315051,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,9,1.02 [0.94-1.1],0.65639282843695,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,4,0.98 [0.91-1.06],0.659596619140345,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_OTH,Inverse variance weighted,3,0.97 [0.85-1.11],0.66926477568118,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,3,0.98 [0.88-1.09],0.690619911435301,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,JOINTPAIN,Inverse variance weighted,3,1.03 [0.9-1.17],0.70786297636836,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_TIA,Wald ratio,1,1.04 [0.84-1.29],0.718167517676425,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,2,1.01 [0.95-1.07],0.720025504411193,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,4,0.98 [0.86-1.11],0.745898209948756,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_CARDMYO,Inverse variance weighted,18,1 [0.98-1.02],0.755469974745101,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Wald ratio,1,1.05 [0.79-1.39],0.756451876756563,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,Wald ratio,1,0.94 [0.65-1.38],0.76214513226415,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,8,0.99 [0.95-1.04],0.771433121297905,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,COPD_LATER,Wald ratio,1,1.01 [0.93-1.1],0.800438585342767,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,Wald ratio,1,0.99 [0.89-1.1],0.818604264864192,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_PULMEMB,Inverse variance weighted,23,1 [0.98-1.03],0.820732219123268,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,I9_STR,Inverse variance weighted,3,0.98 [0.85-1.14],0.823196371363526,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,15,0.99 [0.89-1.1],0.834736239535282,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,2,0.99 [0.86-1.13],0.835337454783018,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,22,1 [0.97-1.04],0.839614267102076,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,10,1.02 [0.87-1.18],0.844931348095044,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOMETPOSTOP,Inverse variance weighted,2,0.99 [0.88-1.11],0.847227154520515,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,J10_EMPHYSEMA,Wald ratio,1,0.99 [0.94-1.05],0.851576599215756,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Wald ratio,1,0.97 [0.71-1.34],0.862721220141951,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Wald ratio,1,1 [0.94-1.05],0.869628055994684,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,4,1.01 [0.94-1.08],0.885490300162547,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Wald ratio,1,1 [0.97-1.04],0.904694367241525,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_VIRAL,Wald ratio,1,1.01 [0.87-1.17],0.916437034454435,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,2,1.01 [0.83-1.23],0.922801204288287,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,K11_CONSTIPATION,Wald ratio,1,1.02 [0.73-1.42],0.927194231250848,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,6,1 [0.96-1.04],0.938294805819886,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,5,1 [0.87-1.13],0.950236202850053,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Wald ratio,1,0.99 [0.72-1.36],0.954803975929319,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,61,1 [0.96-1.04],0.960386913872987,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Wald ratio,1,1 [0.78-1.29],0.991279302394646,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,K11_GALLBILPANC,Inverse variance weighted,21,1 [0.95-1.05],0.993598156163009,trans
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHYOTH,Inverse variance weighted,27,1 [0.92-1.09],0.996525278860797,trans
